Media

Press releases

• Positive results from the Phase Ib clinical study of NeuroRestore ACD856, under development for Alzheimer’s
  June 16, 2026
• The subscription period in AlzeCure Pharma’s Rights Issue begins today
  June 16, 2026
• AlzeCure Pharma enters into a collaboration and out-licensing agreement with Lilly for Alzheimer’s project
  June 9, 2026

All press releases

Calendar

• Annual general meeting 2026 June 29, 2026
• Interim report Q2, April–June 2026 August 26, 2026
• Interim report Q3, July–September 2026 November 11, 2026

All events